0001581881-13-000001.txt : 20130718 0001581881-13-000001.hdr.sgml : 20130718 20130718160648 ACCESSION NUMBER: 0001581881-13-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130718 DATE AS OF CHANGE: 20130718 EFFECTIVENESS DATE: 20130718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vivex Biomedical, Inc. CENTRAL INDEX KEY: 0001581881 IRS NUMBER: 461175687 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-199924 FILM NUMBER: 13974933 BUSINESS ADDRESS: STREET 1: 1755 W. OAK PARKWAY CITY: MARIETTA STATE: GA ZIP: 30062 BUSINESS PHONE: 770-575-5185 MAIL ADDRESS: STREET 1: 1755 W. OAK PARKWAY CITY: MARIETTA STATE: GA ZIP: 30062 D 1 primary_doc.xml X0706 D LIVE 0001581881 Vivex Biomedical, Inc. 1755 W. OAK PARKWAY Suite 200 MARIETTA GA GEORGIA 30062 770-575-5185 GEORGIA None None Corporation true 2012 Tracy Anderson 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Executive Officer Holly Mason 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Executive Officer Michael Rozmajzl 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Executive Officer John Marsh 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Executive Officer Timothy Lusby 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Timothy Taylor 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Jouko R. Rissanen 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director David Greenberg 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Jeffrey A. Smith 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Thomas Greene 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director H. Thomas Temple 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Saadiq El-Amin, III 1755 W. Oak Parkway Suite 200 Marietta GA GEORGIA 30062 Director Biotechnology $1 - $1,000,000 06 false 2013-07-12 false true true false 25000 5500000 2180000 3320000 SERIES A PREFERRED STOCK false 20 0 100000 Estimated consulting fees subject to future engagement of consultant. 300000 false Vivex Biomedical, Inc. Michael Rozmajzl Michael Rozmajzl Secretary 2013-07-18